Skip to main content
. Author manuscript; available in PMC: 2014 Jul 5.
Published in final edited form as: Biochem Biophys Res Commun. 2013 May 29;436(3):10.1016/j.bbrc.2013.05.073. doi: 10.1016/j.bbrc.2013.05.073

Figure 1.

Figure 1

Histopathological changes from lung tissue, showing the effects of LPS with Wy-14643 on WT and PPARα null mice. (A-C) Hematoxylin-eosin (H&E) staining with magnification ×200: (A) WT and Pparα-null mice pretreated with only Wy-14643, (B) WT and Pparα-null mice after intraperitoneal LPS administration, (C) WT and Pparα-null mice with pretreatment of Wy-14643 and intraperitoneal LPS injection, (D) Histology scores of WT and Pparα-null mice. * P < 0.05 different between LPS and LPS with pretreatment of WY-14643; ** P < 0.01 different between LPS and LPS with pretreatment of WY-14643; # P < 0.05 different from the corresponding WT group; ## P < 0.01 different from the corresponding WT group.